These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

194 related items for PubMed ID: 28040287

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Are iso-osmolar, as compared to low-osmolar, contrast media cost-effective in patients undergoing cardiac catheterization? An economic analysis.
    Hiremath S, Akbari A, Wells GA, Chow BJW.
    Int Urol Nephrol; 2018 Aug; 50(8):1477-1482. PubMed ID: 29687326
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. [Contrast-induced nephropathy: An update].
    Spagnoli V, Azzalini L, Tadros VX, Picard F, Ly HQ.
    Ann Cardiol Angeiol (Paris); 2016 Apr; 65(2):87-94. PubMed ID: 26926776
    [Abstract] [Full Text] [Related]

  • 25. Clinically significant contrast induced acute kidney injury after non-emergent cardiac catheterization--risk factors and impact on length of hospital stay.
    Kashif W, Khawaja A, Yaqub S, Hussain SA.
    J Coll Physicians Surg Pak; 2013 Dec; 23(12):842-7. PubMed ID: 24304985
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Contrast-induced nephropathy and risk of acute kidney injury and mortality after cardiac operations.
    Garcia S, Ko B, Adabag S.
    Ann Thorac Surg; 2012 Sep; 94(3):772-6. PubMed ID: 22835553
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Mehran contrast nephropathy risk score: Is it still useful 10 years later?
    Abellás-Sequeiros RA, Raposeiras-Roubín S, Abu-Assi E, González-Salvado V, Iglesias-Álvarez D, Redondo-Diéguez A, González-Ferreiro R, Ocaranza-Sánchez R, Peña-Gil C, García-Acuña JM, González-Juanatey JR.
    J Cardiol; 2016 Mar; 67(3):262-7. PubMed ID: 26169247
    [Abstract] [Full Text] [Related]

  • 36. Contribution of platelets indices in the development of contrast-induced nephropathy.
    Sahin I, Karabulut A, Avci II, Okuyan E, Biter HI, Yildiz SS, Can MM, Gungor B, Dinckal M, Serebruany V.
    Blood Coagul Fibrinolysis; 2015 Apr; 26(3):246-9. PubMed ID: 24695089
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.